BioTrinity Participants
BioTrinity is Europe's Premier BioPartnering and Investment Conference. It brings together investors, pharmaceutical executives and innovative life science R&D companies under one roof. How is this achieved? BioTrinity provides participants with access to each other via one-to one meetings scheduled through the partnering system; at the panel discussions, where panelists can address the tricky questions of the day and in turn, take questions from the audience; and at the exhibition and social events. The conference offers business activities for all participants that can only be achieved at BioTrinity. With a target attendance that exceeds last year’s 800 participants, including 80 investors, if you need to sell your products and services, your company or even yourself, BioTrinity 2013 offers you that forum as many of BioTrinity participants come to the conference to network, partner and do business with other participants. Take a look at the list of companies who have already confirmed attendance at BioTrinity 2013.
BioTrinity 2013 has confirmed attendance of corporate venturers and senior licensing / business development execs from AbbVie, Amgen, AstraZeneca, Boehringer, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, EUSA, GE, Genus, GSK, Ipsen, J&J, Janssen R&D, Mercury Pharma, MSD, Novartis, Novo Nordisk, Shire, Pfizer, Takeda, Teijin, UCB, Vertex, as well as investors from MedImmune Ventures, SR One, Shire Strategic Investment, AbbVie Biotech Ventures, Mitsui & Co., MPHVM, Norgine Investment Fund, Novartis Venture Fund, Takeda Ventures, Boehringer Ingelheim Ventures, Inventages as well as Syncona, Index, Sofinnova and many many others.
Read the testimonials received from delegates from previous years to find out what other delegates say...
Companies Attending BioTrinity 2013:
- 3P Biopharmaceuticals (Spain)
- AbbVie (Belgium)
- AbbVie Biotech Ventures (USA)
- AbD Serotec A Bio-Rad Company
- Abingworth
- Absynth Biologics
- accent Gründerservice GmbH (Austria)
- Advent Life Sciences LLP
- Aesica Pharmaceuticals
- AgPlus Diagnostics
- Agroceutical Products
- Akesios Associates
- Akron Molecules GmbH (Austria)
- Alacrita
- Albion Ventures
- Alida Capital International
- Almac Discovery
- Amgen
- Amorepacific Ventures (South Korea)
- AMRI Global
- Angels4Life Sciences
- AnGes MG (Japan)
- ANGLE plc
- Aniona (Denmark)
- Apex Healthcare Consulting
- Appleyard Lees
- Aptuit (Italy)
- Arachos Pharma
- Ardington Archives
- Arecor
- Argenta Discovery
- Arnold & Porter (UK) LLP
- Arthurian Life Sciences
- Aruwon
- Aquapharm Biodiscovery
- Aquarius Equity Partners
- ASEBIO - Spanish Bioindustry Association (Spain)
- Astell Scientific
- Aston University
- AstraZeneca
- Atelix
- Audion Therapeutics (France)
- Aurelia Bioscience
- Austrian Trade Commission (Austria)
- Austria Wirtschaftsservice (Austria)
- A*Space, UI SAV (Slovakia)
- Avergen
- Avexxin (Norway)
- Avipero
- Bactevo
- Baker Botts (UK) LLP
- BBSRC
- Beta Technology
- BIA
- Bicycle Therapeutics
- Biocat (Spain)
- BioCity
- BioCity Nottingham
- BioDundee
- BioFocus
- BioMoti
- BIONET (Spain)
- BioPark
- BioPharm Insight (FT Group)
- BioScience Slovakia (Slovakia)
- Biosell
- biosurfit (Portugal)
- Biotecnol, Inc (USA)
- Biotechgate
- Biotech Personnel
- Biotec Services International
- Biotrial
- Biovian (Finland)
- Birthsparks
- BIS
- Black Swan Analysis
- Bloomberg News
- Boehringer Ingelheim GmbH, Venture Fund (Germany)
- Boehringer Ingelheim RCV GmbH & Co KG (Austria)
- Bone Therapeutics (Belgium)
- Boult Wade Tennant
- Bristol-Myers Squibb
- Burrill & Company (Switzerland)
- Cabinet Privé de Conselis
- Cambridge Enterprise
- Cambridge Healthcare & Biotech
- CARBOGEN AMCIS AG (Switzerland)
- CASMI
- Catalent
- Cato BioVentures (USA)
- CellCentric
- Cellipse (France)
- Cell Medica
- Celonic GmbH (Germany)
- Celtic Pharma Holdings Advisors LLP
- CEM Analytical Services
- Charles Russell LLP
- CHORD Therapeutics (Switzerland)
- Chilton Tech
- Circa Group Ptd (Australia)
- Circassia
- Citigate Dewe Rogerson
- Clinpak Technologies LLC (USA)
- CMC Biologics (Denmark)
- CMS Cameron McKenna
- Clubb Capital
- College Hill Life Sciences
- Coller IP
- Colworth Science Park
- Communications Strategy Group Inc. (USA)
- Concit Pharma (Denmark)
- Confluence Tax LLP
- Conformetrix
- Congenica
- Coulter Research Operations
- Covagen AG (Switzerland)
- Covington & Burling LLP
- Cranfield University
- Creabilis SA (Luxembourg)
- Crescendo Biologics
- Cresset BioMolecular Discovery
- Critical Pharmaceuticals
- CrSiMA
- Crystallics (Netherlands)
- C-TRIC
- Cyclofluidic
- CytoVac A/S (Denmark)
- Daiichi Sankyo
- Dance Biopharm (USA)
- Dando Weiss and Colucci
- Data Magik
- Debiopharm SA (Switzerland)
- Dehns
- Delta Partners (Ireland)
- Denovo Biomarkers Inc (USA)
- DFJ Esprit LLP
- Dialog Devices
- Diamond Light Source
- Discuva
- Domainex
- Dr. Regenold GmbH (Germany)
- Drug Discovery Today
- Dzaleta Consulting
- Eagle Genomics
- EBD Group (Germany)
- Edinburgh BioQuarter
- Edison Group
- Edmond de Rothschild Investment Partners (France)
- Edwards Wildman Palmer UK LLP
- eg Technology
- Elasmogen
- Electrical Geodesics, Inc. (USA)
- Eli Lilly and Company
- Elsevier
- Emerge Biotech
- Enkam Pharmaceuticals (Denmark)
- Entrepreneurs Fund
- Epiphany Capital
- EP Vantage
- Erevena
- Ernst & Young LLP
- e-Therapeutics plc
- Esperante Ventures (Netherlands)
- ETH Zurich (Switzerland)
- EUCODIS Bioscience GmbH (Austria)
- Eurogentec (Belgium)
- EUSA Pharma (an International Division of Jazz Pharma)
- Evonik Industries AG (Germany and Switzerland)
- Evotec
- F-GHS
- Fibromed
- FibroTx LLC (Estonia)
- FierceBiotech (media)
- Finance Wales
- Fisher Scientific
- Focus Insurances
- Forbion Capital Partners (Netherlands, Germany)
- ForMune S.L. (Spain)
- Forresters
- Fountain Healthcare Partners (Ireland)
- Freemind Group (USA)
- Fry Heath & Spence LLP
- F-Star
- FTS Bio
- Fujifilm Diosynth Biotechnologies
- G&H Associates
- GE Healthcare
- GeneFirst
- GeneFrontier Corporation
- Gene Signal International SA (Switzerland)
- Genus Pharmaceuticals
- george james
- GFA
- Gill Jennings & Every LLP
- GlaxoSmithKline
- Glide Pharmaceutical Technologies
- GlobalAcorn Advanced Therapeutics
- GlobalData Group
- GlySure
- Goodman
- GW Pharmaceuticals plc
- Haemostatix
- Haplogen GmbH (Austria)
- Healthcare at Home
- HealthTIES
- HG Medicines
- HMRC Pharma & R&D Unit
- Hologic Gen-Probe
- Horizon Discovery
- Horton Ruston Poole
- HPA/Public Health England
- Hyper Recruitment Solutions
- ICEX - Spanish Embassy (Spain)
- ICON plc (Ireland)
- Illingworth Research
- Image Analysis Ltd
- IMI Consulting GmbH (Germany)
- Immune Targeting Systems (ITS)
- Immunservice GmbH (Germany)
- Immupharma plc
- Imperial Innovations
- INC Research
- Index Ventures
- Inflection Biosciences (Ireland)
- Informa
- INNOVA Észak-alföld Regional Innovation Agency (Hungary)
- In Silico Genesis
- InSymbiosis (Canada)
- Interea International
- Integrated Magnetic Systems
- Intertek Pharmaceutical Services
- Inventages
- Invest in Oxfordshire
- Iontas
- IP Asset Ventures
- IP Group plc
- Ipsen Biopharm
- Isis Innovation
- Isle of Man Government
- Ithaka Life Sciences
- Janssen R&D
- J A Kemp & Co
- James Cowper LLP
- Janssen R&D
- Johnson & Johnson (USA)
- Karolinska Development (Sweden)
- Karus Therapeutics
- Kelly Scientific Resources
- Kelly Services
- Key Organics
- Kier
- King's College London
- Kreske Nickelsen
- Kreos Capital
- Kurma Life Sciences Partners
- KWS BioTest
- Lacerta Technologies GmbH (Austria)
- Lab Support UK
- Leiras Takeda Pharmaceuticals Oy (Finland)
- Life Sciences Partners (Netherlands)
- Life Length (Spain)
- Liftstream
- Linde Group
- Lipopharma Therapeutics (Spain)
- Locate in Kent
- London Pharma
- Longwall Ventures Partners
- Longbow Capital LLP
- Lonza
- Ludger
- LUMC (Netherlands)
- Lundbeckfond Ventures (Denmark)
- Manches LLP
- Mann Bioinvest
- Maggie's Cheltenham
- Maggie's Oxford
- Mapmyhealth
- Marks & Clerk LLP
- Mathys and Squire LLP
- Medical Delta (Netherlands)
- Melbourn Scientific
- Meng Pharma/Inoxia (Austria)
- MEPC
- Medimmune Ventures (USA)
- Mercia Fund Management
- Mercury Pharma Group
- Mergermarket Group
- Meridian Life Science (USA)
- Merrill DataSite
- Microvisk
- Midven
- Milton Park
- MiNA Therapeutics
- MISSION Therapeutics
- MitoPharm
- Mitsui & USA Co Global Investment (Japan)
- Modern Biosciences plc
- Molecular Detection Inc (USA)
- MP Healthcare Venture Management, Inc. (USA)
- MSD
- Multipharma UK
- MVM Life Science Partners LLP
- Nanotether Discovery Sciences
- NBE-Therapeutics (Switzerland)
- NeoMed (Switzerland)
- Neural Insights
- NeurocentRX Pharma
- Newcastle University
- New Hill Management
- Nomura Code
- Nordic Pharma
- Norgine Investment Fund
- Novartis (USA)
- Novartis Venture Fund (Switzerland)
- Novo A/S (Denmark)
- Novo Seeds (Denmark)
- Novo Nordisk(Denmark)
- Novozymes Biopharma UK
- Nucana Biomed
- Nuevolution (Denmark)
- OBN
- OctoPlus (Netherlands)
- Octopus Investments
- Office for Life Sciences
- ontoforce (Belgium)
- Open University
- OPK Biotech
- OriBase Pharma (France)
- Osborne Clarke
- OSEM
- Oval Medical Technologies
- Oval Insurance Broking
- OWL (Spain)
- Oxford AHSN
- Oxford BioTherapeutics
- Oxford Brookes University
- Oxford Cancer Biomarkers
- Oxford Expression Technologies
- Oxford Gene Technology
- Oxford Local Enterprise Partnership
- Oxford Molecular Diagnostics Centre
- Oxford Medical Diagnostics
- Oxford Pharmascience Group plc
- Oxford Science Park
- Oxford University and Oxford University Hospitals, NHS Trust
- OxSonics
- P & S Nano
- Pacer Therapeutics
- Parkwalk Advisors
- Patheon
- Paul Capital
- Peel Hunt LLP
- Peptinnovate
- Pergamum (Sweden)
- Perkin Elmer LAS
- Pfizer
- PGXIS
- Pharmabioquintet
- Pharmalicensing
- Pharma Publications
- Pharmaterials
- PharmaVentures
- PharmSource
- Phase4 Ventures
- Phico Therapeutics
- PhosphonicS
- Photobiotics
- Physiomics plc
- Pinsent Masons
- Piramal Discovery (India)
- Piramal Enterprises
- Piramal Healthcare (India)
- Planimeter Kft. (Hungary)
- Plethora Solutions
- Ploughshare Innovations
- PolyTherics
- Pricespective, An ICON plc Company
- Progenitor Labs
- ProPharma Partners
- Prosonix
- Providion
- Province South Holland (Netherlands)
- PsiOxus Therapeutics
- Public Health England
- Q Chip
- QIPP Right Care
- QRC Consultants
- Quay Pharma
- Queen's University Belfast
- QuickSTAT
- Quintiles
- Quotient Bioresearch
- Quotient Clinical
- Rainbow Seed Fund
- Reading Scientific Services Ltd (RSSL)
- Recardio GmbH (Austria)
- RedHill Biopharma (Israel)
- Red Hot Biotech Alert
- Redoxis AB (Sweden)
- Regulatory Resources Group
- Remtec Search & Selection
- ReNeuron plc
- Riverbank IT Management
- Rock Spring Ventures
- Royal Society Enterprise Fund
- RTC S.p.A. (Italy)
- Safeguard Biosystems Holdings
- Saretius
- Savira Pharmaceuticals (Austria)
- Science-to-Market GmbH (Germany)
- SCM Pharma
- Scottish Development International
- SCRIP Intelligence (Media)
- Selcia
- Sequani
- Seroba Kernel
- Seventure Partners (France)
- Shire Pharmaceuticals
- Shire Strategic Investments (USA)
- Shoosmiths LLP
- Silicon Valley Bank
- Simbec Research
- SmartSensor Telemed
- Sofinnova Partners (France)
- Sony DADC Biosciences
- Source BioScience
- Spanish Embassy (Spain)
- Spanish Embassy Commercial Office
- Springer (USA)
- SR One
- SRG
- SRG Synergy Outsourcing
- Standortagentur Tirol (Austria)
- Stemedica International SA (Switzerland)
- Stevenage Bioscience Catalyst
- STJ Advisors
- Summit Corporation plc
- SurgaColl Technologies (Ireland)
- SV Life Sciences Advisers LLP
- Swansea University
- Swiss Biotech Association (Switzerland)
- Sygnature Discovery
- Symbiosis Pharmaceutical Services
- Synairgen Research
- Syncona Fund
- Syncona Partners
- Syncrosome (France)
- Synpromics
- Syntaxin
- Takeda Pharmaceuticals (Europe and US)
- Takeda UK
- Takeda Ventures, Inc. (USA)
- Talentmark
- TBD-Biodiscovery (Estonia)
- Technology Strategy Board
- Teijin Pharma
- The Oval Group
- Theryte
- Theobald Associates
- The Welsh Government
- Tillotts Pharma AG (Switzerland)
- to-BBB technologies BV (Netherlands)
- TopiVert Pharma
- Torreya Partners (USA)
- Total Scientific
- TPG Biotech
- TPP Global Development
- TranScrip Partners LLP
- TriMod Therapeutics (Ireland)
- Tukan Partners
- TVM Capital GmbH (Germany)
- UCB
- UD-GenoMed (Hungary)
- UK Bio Incubator Forum (UKBIF)
- UKTI (UK)
- UKTI United States (USA)
- UKTI France (France)
- UKTI Moscow (Russian Federation)
- UKTI Spain (Spain)
- UKTI Sweden (Sweden)
- UKTI Warsaw (Poland)
- UMI3
- uniQure BV (Netherlands)
- University College London
- University of Buckingham
- University of Cambridge
- University of Dundee
- University of Liverpool
- University of Nottingham
- University of Oxford
- University of Reading
- Venn Life Sciences
- Venner Shipley LLP
- Ventac Partners (Spain)
- Venter Pharma SL (Spain)
- Veredus
- Vernalis plc
- Vertex Pharmaceuticals Europe
- VHsquared
- Vidara Therapeutics (Ireland)
- ViroPharma (Belgium)
- VitalSix
- VolitionRx (Belgium)
- Warwick Ventures
- Wellington Partners (Germany)
- Welsh Government
- Western Provident Association
- WG Partners
- WilmerHale
- World Courier (UK)
- Wragge & Co LLP
- Xenetic Biosciences
- Xplico (Denmark)
- Xiber Science GmbH (Austria)
- Ysios Capital Partners (Spain)
- Zestagen SA (Switzerland)
- Zoticon BioVentures (Israel)